Go Pro
→ This sub-5 dollar stock operates next to SpaceX and Blue Origin (From Freedom Financial) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$12.27
-8.0%		$11.62
$3.71
▼
$14.19
$220.80M1.7189,932 shs75,985 shs
DarioHealth Corp. stock logo
DRIO
DarioHealth
$6.82
-3.0%		$7.20
$5.84
▼
$17.74
$68.89M1.1224,682 shs6,322 shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.73
+1.8%		$1.95
$0.96
▼
$3.62
$127.94M1.53575,589 shs582,423 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$7.17
-5.7%		$7.09
$4.54
▼
$22.25
$143.15M1.09226,375 shs78,512 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
-7.93%-4.82%-9.25%+34.69%+79.52%
DarioHealth Corp. stock logo
DRIO
DarioHealth
-2.99%-6.58%-10.97%-5.28%-25.38%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
+1.76%+2.37%+0.58%+5.49%-49.12%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-5.66%-10.82%+4.52%+35.80%-59.70%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$12.27
-8.0%		$11.62
$3.71
▼
$14.19
$220.80M1.7189,932 shs75,985 shs
DarioHealth Corp. stock logo
DRIO
DarioHealth
$6.82
-3.0%		$7.20
$5.84
▼
$17.74
$68.89M1.1224,682 shs6,322 shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.73
+1.8%		$1.95
$0.96
▼
$3.62
$127.94M1.53575,589 shs582,423 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$7.17
-5.7%		$7.09
$4.54
▼
$22.25
$143.15M1.09226,375 shs78,512 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
-7.93%-4.82%-9.25%+34.69%+79.52%
DarioHealth Corp. stock logo
DRIO
DarioHealth
-2.99%-6.58%-10.97%-5.28%-25.38%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
+1.76%+2.37%+0.58%+5.49%-49.12%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-5.66%-10.82%+4.52%+35.80%-59.70%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.00
Hold$9.50-22.58% Downside
DarioHealth Corp. stock logo
DRIO
DarioHealth
2.25
Hold$10.0046.63% Upside
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.18
Hold$2.4541.62% Upside
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
2.56
Moderate Buy$11.4359.39% Upside

Current Analyst Ratings Breakdown

Latest DRIO, AMWL, OPRX, and HCAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
8/20/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$3.00 ➝ $1.80
8/19/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
Alliance Global Partners logo
Alliance Global Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$12.00
8/14/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$11.00
8/14/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
8/14/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Outperform$9.00 ➝ $11.00
8/13/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$12.00
8/13/2026
American Well Corporation stock logo
AMWL
American Well
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetHold$7.50 ➝ $12.00
8/13/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$1.75 ➝ $1.50
8/12/2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$11.00 ➝ $8.00
8/11/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$249.32M0.81N/AN/A$14.97 per share0.82
DarioHealth Corp. stock logo
DRIO
DarioHealth
$21.00M3.18N/AN/A$10.05 per share0.68
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$311.14M0.42$2.16 per share0.80$3.47 per share0.50
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$109.43M1.23$0.93 per share7.72$6.88 per share1.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$95.70M-$4.77N/AN/AN/A-35.75%-30.12%-22.30%11/3/2026 (Estimated)
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$41.71M-$6.13N/AN/AN/A-169.87%-54.81%-33.36%11/12/2026 (Estimated)
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$177.97M-$3.68N/AN/AN/A-90.61%-1.83%-0.80%11/9/2026 (Estimated)
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$5.13M$0.2331.1810.54N/A4.66%9.44%7.11%11/5/2026 (Estimated)

Latest DRIO, AMWL, OPRX, and HCAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$0.1111$0.16+$0.0489-$0.04$20.20 million$20.50 million
8/11/2026Q2 2026
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$1.22-$0.85+$0.37-$0.85$5.92 million$5.18 million
8/6/2026Q2 2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$0.0299$0.04+$0.0101-$0.55$69.09 million$70.49 million
8/4/2026Q2 2026
American Well Corporation stock logo
AMWL
American Well
-$0.86-$0.59+$0.27-$0.59$49.87 million$52.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
DarioHealth Corp. stock logo
DRIO
DarioHealth
N/AN/AN/AN/AN/A
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.90
2.89
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.56
2.31
1.92
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1.51
2.70
2.70
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.14
5.58
5.58

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
DarioHealth Corp. stock logo
DRIO
DarioHealth
33.39%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
85.00%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
76.47%

Insider Ownership

CompanyInsider Ownership
American Well Corporation stock logo
AMWL
American Well
12.84%
DarioHealth Corp. stock logo
DRIO
DarioHealth
3.50%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
19.40%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04016.55 million14.43 millionOptionable
DarioHealth Corp. stock logo
DRIO
DarioHealth
2009.80 million9.46 millionNo Data
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1,20075.26 million60.66 millionOptionable
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
10018.84 million17.42 millionOptionable

Recent News About These Companies

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
September 8 at 7:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357523/0/en/optimizerx-to-participate-in-the-10th-annual-lake-street-best-ideas-growth-conference.html
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
September 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355013/0/en/optimizerx-appoints-pharma-commercialization-and-ai-expert-troy-sarich-as-company-advisor.html
OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Recommendation of "Moderate Buy" from Analysts
August 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30994781
OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-optimizerx-corp-nasdaq-oprx-given-average-rating-of-moderate-buy-by-analysts-2026-08-26/
AWM Investment Company Inc. Invests $1.38 Million in OptimizeRx Corp. $OPRX
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-awm-investment-company-inc-invests-138-million-in-optimizerx-corp-oprx-2026-08-26/
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
August 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/optimizerx-oprx-q2-2026-earnings-234407133.html
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-nasdaqoprx-stock-price-expected-to-rise-citizens-jmp-analyst-says-2026-08-14/
Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-has-136-million-stock-position-in-optimizerx-corp-oprx-2026-08-14/
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
August 13, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/optimizerx-corp-oprx-q2-2026-050346456.html
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/optimizerx-announces-finance-leadership-appointments-200500530.html
OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition
August 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4632012-optimizerx-reiterates-95m-100m-2026-revenue-outlook-amid-cfo-transition
OptimizeRx Q2 Earnings Call Highlights
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-q2-earnings-call-highlights-2026-08-12/
OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935660-optimizerx-corporation-oprx-q2-2026-earnings-call-transcript
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
August 12, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2973878/optimizerx-corp-oprx-q2-earnings-and-revenues-top-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2973878
OptimizeRx (NASDAQ:OPRX) Announces Earnings Results, Beats Estimates By $0.05 EPS
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-nasdaqoprx-announces-earnings-results-beats-estimates-by-005-eps-2026-08-12/
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline
August 12, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/optimizerx-reaffirms-2026-outlook-amid-revenue-decline?utm_source=marketbeat.com&utm_medium=referral
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/12/3344034/0/en/optimizerx-reports-second-quarter-2026-financial-results-and-updates-fiscal-year-2026-guidance.html
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335125/0/en/optimizerx-sets-second-quarter-2026-conference-call-for-august-12-2026-at-4-30-p-m-et.html
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332033/0/en/optimizerx-appoints-veteran-point-of-care-marketing-leader-sarah-bast-as-chief-marketing-officer.html
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319553/0/en/optimizerx-launches-copaycue-a-next-generation-copay-activation-solution-powered-by-real-time-prescribing-intent.html
OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms
June 25, 2026  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$12.27 -1.07 (-8.02%)
Closing price 09/9/2026 03:59 PM Eastern
Extended Trading
$12.14 -0.13 (-1.09%)
As of 08:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

DarioHealth stock logo

DarioHealth NASDAQ:DRIO

$6.82 -0.21 (-2.99%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$6.85 +0.03 (+0.44%)
As of 09/9/2026 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Health Catalyst stock logo

Health Catalyst NASDAQ:HCAT

$1.73 +0.03 (+1.76%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$1.72 0.00 (-0.29%)
As of 09/9/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$7.17 -0.43 (-5.66%)
Closing price 09/9/2026 04:00 PM Eastern
Extended Trading
$7.14 -0.03 (-0.43%)
As of 08:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas